Intrater James 4

What Happened
James Intrater, a director of Cardio Diagnostics Holdings, Inc. (CDIO), received an award/acquisition of 3,205 derivative shares on March 31, 2026. The filing shows an acquisition price of $1.95 per share, giving an aggregate reported value of approximately $6,250. This was reported as an award/derivative grant (Form 4 code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-31; Filing date (accession): 2026-04-02. The Form 4 appears to have been filed on time.
• Instrument: Derivative securities awarded (code A); reported price $1.95 per share.
• Shares acquired: 3,205; reported aggregate value: ~$6,250.
• Shares owned after transaction: Not specified in the provided summary.
• No footnotes or 10b5-1/tax-withholding details provided in the supplied data.

Context
An "award" of derivative securities typically represents compensation (for example, restricted stock units or similar awards) that may vest into common shares in the future; it is different from a market purchase or sale. Such grants are common for directors and executives and do not by themselves indicate immediate buying/selling pressure. The reported dollar amount here is modest relative to most insider trades.